Pathomic immune biomarkers define recurrence risk in early-stage melanoma

Immune biomarkers should be prospectively validated in stage II-III melanoma for the purpose of avoiding overtreatment of low-risk patients and to stratify high-risk patients for clinical trials.

Authors

Institutions

Publication Details

Journal
The Oncologist
Published
2025-10-01
DOI
https://doi.org/10.1093/oncolo/oyaf327
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pathomic immune biomarkers define recurrence risk in early-stage melanoma

Chaoyuan Kuang, Swanand Rakhade, Tammie Ferringer, Thazin Nwe Aung et al.
1 citations
The Oncologist
Cancer Immunotherapy and Biomarkers
1.05
article

Pathomic immune biomarkers define recurrence risk in early-stage melanoma

Chaoyuan Kuang, Swanand Rakhade, Tammie Ferringer, Thazin Nwe Aung, Robyn D. Gartrell, David L. Rimm, Kent L. Nastiuk, Matteo Abbruzzese, Gerardo Espinoza, Sharmin Sultana, Lawrence W. Leung, Basil A. Horst, Jee‐Young Moon, Yvonne M. Saenger, David Entenberg, Yadriel Bracero, Suryansh Shukla, Ajay Singh, Chenxin Zhang, Rui Chang, Larisa J. Geskin, Tianyun Jiang, Divya Kenchappa, Emily Nghiem
article en
1 citations

Abstract

Immune biomarkers should be prospectively validated in stage II-III melanoma for the purpose of avoiding overtreatment of low-risk patients and to stratify high-risk patients for clinical trials.

The OncologistVol. 30(10)
Roswell Park Comprehensive Cancer Center (US), Albert Einstein College of Medicine (US), University of Arizona (US), University of British Columbia (CA), Johns Hopkins University (US), Critical Path Institute (US), Johns Hopkins Bayview Medical Center (US), Yale University (US), Columbia College (CA), Geisinger Health System (US), Columbia University (US)
National Institutes of Health, National Cancer Institute
Openalex Percentile: Top 17%
Cancer Immunotherapy and Biomarkers
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.